Venovenous extracorporeal membrane oxygenation (VV-ECMO) for severe acute respiratory distress syndrome (ARDS) in adults—a single-center experience
Authors:
Open Access
- 30 July 2024
- journal article
- research article
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 18 (1) , 1-10
Abstract
Background: The survival benefit of venovenous extracorporeal membrane oxygenation (VV-ECMO) in adult patients with severe acute respiratory distress syndrome (ARDS) remains controversial. This study aimed to investigate the efficiency and potential prognostic factors of VV-ECMO for severe ARDS in adults by evaluating our institutional experience and results. Materials and methods: This research studied ARDS patients receiving VV-ECMO between June 2011 and May 2023. The inclusion criteria were PaO2/FiO2 < 100 mmHg at FiO2 of 1.0. Retrospective data was analyzed to identify factors associated with successful ECMO weaning and hospital discharge survival. Results: A total of 18 patients were included in this study, with 7 cases (38.9%) successfully weaned from ECMO and 5 cases (27.8%) surviving hospital discharge. The overall complication rate was 77.8%. After treatment with VV ECMO, there were statistically significant improvements in both PaO2 and PaCO2 (P < 0.05). Patients in the successful weaning group had a lower pTB value, less accumulative volume of sodium bicarbonate during ECMO, and lower accumulative volume of intravenous immunoglobulin in the hospital compared to the unsuccessful weaning group (all P < 0.05). Furthermore, compared to the non-survivors, the survivors had less severe acidosis, higher mean arterial pressure before ECMO, a lower level of pCr, and a lower pTB value during ECMO (all P < 0.05). Conclusion: ECMO can effectively promote oxygenation and carbon dioxide (CO2) removal in patients with severe ARDS. Early initiation of ECMO with appropriate management could benefit in reducing comorbidities and mortality.Keywords
Funding Information
- National Natural Science Foundation of China (82374216)
- Medical Scientific Research Foundation of Guangdong Province of China (A2023198, A2024135)
- Zhongshan Science and Technology Bureau (2020B1081)
This publication has 31 references indexed in Scilit:
- Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysisIntensive Care Medicine, 2021
- Blood Transfusion Threshold in Patients Receiving Extracorporeal Membrane Oxygenation Support for Cardiac and Respiratory Failure—A Systematic Review and Meta-AnalysisJournal of Cardiothoracic and Vascular Anesthesia, 2021
- Transfusion Thresholds for Adult Respiratory Extracorporeal Life Support: An Expert Consensus DocumentCanadian Journal of Cardiology, 2020
- Updates in Pediatric Extracorporeal Membrane OxygenationJournal of Cardiothoracic and Vascular Anesthesia, 2020
- Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trialThe Lancet, 2018
- Outcomes after Angiography with Sodium Bicarbonate and AcetylcysteineNew England Journal of Medicine, 2018
- Bilirubin in the early course of venovenous extracorporeal membrane oxygenation support for refractory ARDSJournal of Artificial Organs, 2017
- Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysisIntensive Care Medicine, 2016
- Venovenous extracorporeal membrane oxygenation for acute respiratory failureIntensive Care Medicine, 2016
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesJAMA, 2016